1. Home
  2. PLSE vs NVEE Comparison

PLSE vs NVEE Comparison

Compare PLSE & NVEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • NVEE
  • Stock Information
  • Founded
  • PLSE 2014
  • NVEE 1949
  • Country
  • PLSE United States
  • NVEE United States
  • Employees
  • PLSE N/A
  • NVEE N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • NVEE Other Consumer Services
  • Sector
  • PLSE Health Care
  • NVEE Consumer Discretionary
  • Exchange
  • PLSE Nasdaq
  • NVEE Nasdaq
  • Market Cap
  • PLSE 1.1B
  • NVEE 1.0B
  • IPO Year
  • PLSE 2016
  • NVEE 2013
  • Fundamental
  • Price
  • PLSE $16.88
  • NVEE $22.10
  • Analyst Decision
  • PLSE
  • NVEE Buy
  • Analyst Count
  • PLSE 0
  • NVEE 4
  • Target Price
  • PLSE N/A
  • NVEE $25.67
  • AVG Volume (30 Days)
  • PLSE 154.2K
  • NVEE 860.0K
  • Earning Date
  • PLSE 05-08-2025
  • NVEE 05-01-2025
  • Dividend Yield
  • PLSE N/A
  • NVEE N/A
  • EPS Growth
  • PLSE N/A
  • NVEE N/A
  • EPS
  • PLSE N/A
  • NVEE 0.45
  • Revenue
  • PLSE N/A
  • NVEE $962,752,000.00
  • Revenue This Year
  • PLSE N/A
  • NVEE $11.23
  • Revenue Next Year
  • PLSE N/A
  • NVEE $5.16
  • P/E Ratio
  • PLSE N/A
  • NVEE $49.54
  • Revenue Growth
  • PLSE N/A
  • NVEE 8.74
  • 52 Week Low
  • PLSE $9.70
  • NVEE $14.75
  • 52 Week High
  • PLSE $25.00
  • NVEE $26.14
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 48.47
  • NVEE 67.99
  • Support Level
  • PLSE $16.75
  • NVEE $22.02
  • Resistance Level
  • PLSE $18.26
  • NVEE $22.50
  • Average True Range (ATR)
  • PLSE 0.86
  • NVEE 0.56
  • MACD
  • PLSE 0.03
  • NVEE -0.00
  • Stochastic Oscillator
  • PLSE 48.82
  • NVEE 85.60

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About NVEE NV5 Global Inc.

NV5 Global Inc is a provider of technology, conformity assessment, and consulting solutions to public and private sector clients in the infrastructure, utility services, construction, real estate, environmental, and geospatial markets, operating nationwide and abroad. The Company's clients include the U.S. Federal, state and local governments, and the private sector. The operating business segments are Infrastructure, Building, Technology & Sciences, and Geospatial Solutions. The maximum revenue derives from the infrastructure segment.

Share on Social Networks: